CLOSTRIDIOIDES DIFFICILE INFECTION
Clinical trials for CLOSTRIDIOIDES DIFFICILE INFECTION explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIOIDES DIFFICILE INFECTION trials appear
Sign up with your email to follow new studies for CLOSTRIDIOIDES DIFFICILE INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Poop pills vs antibiotics: new hope for gut infection?
Disease control Recruiting nowThis study tests whether a fecal microbiota transplant (FMT) given after standard antibiotics can prevent C. diff infection from coming back. About 220 adults with a first or first-recurrence C. diff infection will either get antibiotics alone or antibiotics followed by FMT capsu…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE3 • Sponsor: Benoit Guery • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Poop transplants tested for ulcerative colitis relief
Disease control Recruiting nowThis study is testing whether fecal microbiota transplantation (FMT), or a 'poop transplant,' can help people with ulcerative colitis achieve remission without steroids. About 85 adults with active disease will receive either FMT or a placebo. The main goal is to see if a larger …
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE1 • Sponsor: University of Alberta • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
Simple vancomycin pill may stop c. diff from coming back during antibiotic treatment
Disease control Recruiting nowThis study tests whether taking oral vancomycin can prevent a repeat Clostridioides difficile infection in people who recently had one and now need another antibiotic. About 300 adults will receive either vancomycin or a placebo while on antibiotics, plus a week after. The goal i…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Could a 14-Day pill break the cycle of recurrent c. diff?
Prevention Recruiting nowThis study tests a new treatment called VE303 to see if it can prevent repeat Clostridioides difficile (C. diff) infections. About 852 people who have had C. diff before will take either VE303 or a placebo for 14 days. The main goal is to see if fewer people get another C. diff i…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Prevention
Last updated May 26, 2026 05:41 UTC
-
Could a single friendly gut bacterium break the cycle of recurrent c. diff?
Prevention Recruiting nowThis study tests EXL01, a capsule containing a single beneficial gut bacterium (Faecalibacterium prausnitzii), to see if it can prevent repeat Clostridioides difficile infections in people at high risk. About 56 adults who have had at least two or three C. diff episodes will take…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated May 22, 2026 13:52 UTC
-
New drug aims to break the cycle of repeat c. diff infections
Prevention Recruiting nowThis study tests an experimental drug called AZD5148 to see if it can prevent Clostridioides difficile (C. diff) infections from returning in adults aged 18 and older. About 230 participants will receive either the drug or a placebo. The goal is to reduce the number of repeat inf…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Prevention
Last updated May 20, 2026 11:56 UTC
-
New drug aims to break the cycle of recurring c. diff infections
Prevention Recruiting nowThis study tests an experimental drug called LMN-201 to see if it can prevent C. difficile infections from returning after standard antibiotic treatment. About 375 adults with a recent C. diff infection will receive either LMN-201 or a placebo. The main goal is to see if more peo…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Lumen Bioscience, Inc. • Aim: Prevention
Last updated May 11, 2026 20:41 UTC
-
Scientists track c. diff patients for 5 years to unlock best treatment secrets
Knowledge-focused Recruiting nowThis study follows 200 adults with C. diff infection to see how standard antibiotics and fecal microbiota transplantation (FMT) work. Researchers will collect stool, blood, urine, and nasal samples, and track recovery for up to 5 years. The goal is to understand which treatments …
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Sponsor: Umeå University • Aim: Knowledge-focused
Last updated May 26, 2026 04:36 UTC